申请人:BASF Aktiengesellschaft
公开号:US05270325A1
公开(公告)日:1993-12-14
p-hydroxy phenone derivatives of the formula I ##STR1## where X is ##STR2## where R.sup.1 =F, Cl, Br or trifluoromethyl or a heteroaryl of the structure ##STR3## with R.sup.2 =C.sub.1 -C.sub.4 -alkyl, Y is a bridging member of the formula --CH.dbd.CH--, --CH.sub.2 CH.sub.2 -- or --CH.sub.2 --, n is one of the numbers 2, 3 or 4 and Z is an amino group of the formula --NR.sup.2 R.sup.3 or N-pyrrolidyl or N-piperidyl, where R.sup.2 and R.sup.3 are, independently of one another, C.sub.1 -C.sub.4 -alkyl, as well as the physiologically tolerated salts thereof, are used for preparing drugs.
公式I中的对羟基苯甲酮衍生物为:##STR1## 其中X为##STR2## 其中R.sup.1 = F、Cl、Br或三氟甲基或结构为##STR3##的杂环基,R.sup.2 = C.sub.1-C.sub.4-烷基,Y为式--CH.dbd.CH--、--CH.sub.2CH.sub.2--或--CH.sub.2--的桥接成员,n为数字2、3或4,Z为式--NR.sup.2R.sup.3或N-吡咯烷基或N-哌啶基的氨基基团,其中R.sup.2和R.sup.3独立地为C.sub.1-C.sub.4-烷基,以及其生理上耐受的盐,用于制备药物。